News

This week’s report includes the latest from Gilead, Janssen, Spero Therapeutics, Clorox, and TECHLAB.

Obstacles to achieving durable HIV remission in lower- and middle-income countries affects these nations’ ability to carry out needed research.

Recent research shows no clinical benefits from adding azithromycin to standard treatment for adults who presented to emergency departments with acute asthma exacerbations requiring a corticosteroid course.

A new analysis looks into the role of sanitation on infectious disease and nutrition.

With new human cases of West Nile virus springing up and more states reporting mosquitoes testing positive for the virus, health officials note that this may be an earlier start to the West Nile season than has been seen in past years.

Challenges to public health are never-ending and experts argue that budget cuts that will be made through the American Health Care Act (AHCA) will have dire consequences to how we can respond.

Researchers from Midwestern University Chicago College of Pharmacy highlight correlations between antibiotic use and horizontal transmission of Vancomycin-resistant Enterococcus (VRE) bacterial species.

Researchers from the University of Nebraska Medical Center conducted a trial to measure if using a specific device for blood collection would reduce the rate of culture contamination.

In a recent webinar, CDC officers discussed challenges in diagnosing Lyme disease, and options to improve diagnostic rates.

A recent scabies outbreak has affected a Chicago daycare facility, forcing students and teachers experiencing symptoms to be sent home.

NIAID researchers have discovered that a rare genetic mutation can increase susceptibility to catching human rhinoviruses.

A viral protein may be behind the rapid spread of the Ebola virus.

Updates to the EML highlight the dangerous growing threat of antimicrobial resistance and the dire situation we are currently facing.

The results of a new study in the Journal of the American Medical Association (JAMA) provide strong evidence that the goals of the United Nation’s Program on HIV/AIDS (UNAIDS) are indeed possible.

Superbugs, Zika, antibiotic development, C. difficile, and HIV are the article topics making up this week’s Top 5 articles.

The impact of viruses on community-acquired pneumonia seems to be greater than initially realized and the use of procalcitonin may help distinguish infection type for appropriate treatment.

A new study sheds more light on a recent cluster of gonorrhea infections in Hawaii, the strain of which is showing resistance to the two antibiotics recommended to effectively treat the sexually transmitted disease.

Contagion® sat down with Rodrigo Mendes, PhD, to discuss research exploring evolving resistance among antibiotics to treat skin infections.

Health officials across the country have linked Salmonella outbreaks spanning 47 states to live poultry and the growing popularity of keeping backyard flocks.

The weekly Business Watch includes the latest industry news that practitioners working in infectious diseases need to know.

Conan MacDougall, PharmD, MAS, BCPS-AQ ID, sheds light on behavior change interventions that could positively affect antibiotic prescribing practices.

In the most recent MMWR, the CDC released data indicating the risk of Zika congenital infection resulting into complications based on trimester of infection.

May's top articles included news on HIV, Lyme disease, updates to nosocomial pneumonia guidelines, and more.

In patients who are being treated with antiretroviral therapy (ART), it appears that a latent form of HIV residing in immune cells can continue to reproduce.

While health departments around the country continue to report that mosquitoes are testing positive for the West Nile virus, researchers have received a federal grant to study the neurological effects of the virus.

Incidence of superbug infections are certainly keeping the media in business, but is all the attention translating into an increased awareness of the importance of antibiotic stewardship?

New research suggests that making drug use a crime may negatively impact the prevention and treatment of HIV.

Researchers describe how government and pharmaceutical companies develop are working to develop new drugs for emerging infectious diseases.